Posted by jrbecker on June 30, 2003, at 11:53:18
for all that are interested, there is an interesting webcast presentation going on by DOV pharmaceuticals http://www.dovpharm.com on their pipeline of new anxiety compounds including their lead drug, ocinaplon, which is an anxiolytic (starting phase III) that shows promise as the first of a new class of GABAergic drugs without sedative effects(GABA-A sub-specific agonist) to hit the market. Ocinaplon is slightly similar in nature but very pharmacologically distinct from Indevus's Pagoclone that is in phase III trials. The presenation also covers indiplon, their new sleep agent due to for NDA early next year. They'll also be probably talking about their triple-reuptake inhibitor program for treatment of depression.
The presentation will also be archived for those that can't watch it now.
poster:jrbecker
thread:238127
URL: http://www.dr-bob.org/babble/20030624/msgs/238127.html